These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26644877)

  • 1. Histological changes of kidney in diabetic nephropathy.
    Pourghasem M; Shafi H; Babazadeh Z
    Caspian J Intern Med; 2015; 6(3):120-7. PubMed ID: 26644877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus.
    Zhuo L; Zou G; Li W; Lu J; Ren W
    Eur J Med Res; 2013 Feb; 18(1):4. PubMed ID: 23432977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
    Carmona M; Paco-Meza LM; Ortega R; Cañadillas S; Caballero-Villarraso J; Blanco A; Herrera C
    Pathol Res Pract; 2022 Feb; 230():153756. PubMed ID: 35032832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Management of Diabetic Nephropathy in Western Countries.
    Satirapoj B; Adler SG
    Kidney Dis (Basel); 2015 May; 1(1):61-70. PubMed ID: 27536666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting Experimental Models of Diabetic Nephropathy.
    Giralt-López A; Molina-Van den Bosch M; Vergara A; García-Carro C; Seron D; Jacobs-Cachá C; Soler MJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of intrarenal product TNF-alpha in the development of glomerular and tubulointerstitial tissues changes in elderly patients with diabetic nephropathy].
    Rakitianskaia IA; Riabov SI; Azanchevskaia SV; Riabova TS; Al-Barbari K; Gurkov AS; Popova VB
    Adv Gerontol; 2013; 26(4):658-65. PubMed ID: 24738256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats.
    Peng T; Chang X; Wang J; Zhen J; Yang X; Hu Z
    Mol Med Rep; 2017 May; 15(5):3172-3178. PubMed ID: 28339051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Deposition Predicts Worsening Kidney Function and Underlines the Clinical Significance of the 2010 Renal Pathology Society Classification of Diabetic Nephropathy.
    Jiang S; Di D; Jiao Y; Zou G; Gao H; Li W
    Front Immunol; 2022; 13():868127. PubMed ID: 35711407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective cohort study on the pathology and outcomes of type 2 diabetic patients with renal involvement.
    Li M; Li CM; Ye ZC; Rao JL; Peng H; Lou TQ
    Int Urol Nephrol; 2021 Feb; 53(2):333-341. PubMed ID: 33021708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Clinicopathological Study of 267 Patients with Diabetic Kidney Disease Based on the Renal Pathology Society - 2010 Classification System.
    Chandragiri S; Raju SB; Mandarapu SB; Goli R; Nimmagadda S; Uppin M
    Indian J Nephrol; 2020; 30(2):104-109. PubMed ID: 32269434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy, a targeted treatment for diabetic nephropathy.
    Lin X; Tao L; Tang D
    Curr Med Chem; 2013; 20(30):3774-84. PubMed ID: 23895680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy.
    Talukdar A; Basumatary M
    Mol Biol Rep; 2023 Sep; 50(9):7759-7782. PubMed ID: 37458869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy: Is it time yet for routine kidney biopsy?
    Gonzalez Suarez ML; Thomas DB; Barisoni L; Fornoni A
    World J Diabetes; 2013 Dec; 4(6):245-55. PubMed ID: 24379914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renalase regulates renal tubular injury in diabetic nephropathy via the p38MAPK signaling pathway.
    Zhang L; Zang CS; Chen B; Wang Y; Xue S; Wu MY
    FASEB J; 2023 Oct; 37(10):e23188. PubMed ID: 37732586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria.
    Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
    Nephrology (Carlton); 2012 Jan; 17(1):68-75. PubMed ID: 21933307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence and Management of Diabetic Nephropathy in Asia.
    Tomino Y; Gohda T
    Kidney Dis (Basel); 2015 May; 1(1):52-60. PubMed ID: 27536665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway.
    Guo M; Gao J; Jiang L; Dai Y
    Drug Des Devel Ther; 2023; 17():2107-2118. PubMed ID: 37489175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.